Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FF76A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,552
Award facts
- Contract value 100% obligated
- $19,552.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,552.25 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 mL formulation on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 pharmaceutical prime vendor vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting presence as a critical vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition, delivering everything from specialty medications and vaccines to medical devices and diagnostic supplies across multiple therapeutic domains. This particular delivery order for Cosentyx, a biologic immunosuppressant used in treating inflammatory conditions, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare customers through flexible contracting vehicles.
Quick answers
Who was awarded contract SPE2DB25FF76A?
SPE2DB25FF76A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FF76A worth?
The government has obligated $19,552 on SPE2DB25FF76A.
Is contract SPE2DB25FF76A an order under another contract?
Yes. SPE2DB25FF76A is a delivery order under SPE2DB20D1047, an indefinite delivery contract.
Was contract SPE2DB25FF76A competed?
The extent of competition for SPE2DB25FF76A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award